Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis.

Saved in:
Bibliographic Details
Title: Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis.
Authors: Stapleton, Amanda L.1 (AUTHOR), Kimple, Adam2 (AUTHOR), Goralski, Jennifer L.3 (AUTHOR), Beswick, Daniel M.4 (AUTHOR), Gupta, Anshika5,6 (AUTHOR), Li, Douglas A.7 (AUTHOR), Branstetter, Barton F.1,8 (AUTHOR), Nouraie, S. Mehdi6 (AUTHOR), Shaffer, Amber D.1 (AUTHOR), Senior, Brent2 (AUTHOR), Zemke, Anna C.6 (AUTHOR) zemkea@upmc.edu
Source: International Forum of Allergy & Rhinology. Jul2025, Vol. 15 Issue 7, p706-714. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20426976
DOI:10.1002/alr.23555